1
Clinical Trials associated with LX-103 (Innostellar) / RecruitingNot ApplicableIIT An Open Label Dose Escalation Clinical Trial to Evaluate the Safety and the Efficacy of LX103 in Patients With X-Linked Retinoschisis (XLRS)
The goal of this study is to evaluate the safety and efficacy of LX103 treatment of X-linked retinoschisis. This study will enroll subjects aged ≥ 6 years old to receive a single unilateral intravitreal (IVT) injection of LX103 to evaluate its safety and efficacy.
100 Clinical Results associated with LX-103 (Innostellar)
100 Translational Medicine associated with LX-103 (Innostellar)
100 Patents (Medical) associated with LX-103 (Innostellar)
100 Deals associated with LX-103 (Innostellar)